Work

Phase II trial of nintedanib in patients with bevacizumab-resistant recurrent epithelial ovarian, tubal, and peritoneal cancer

Year: 2019

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2019.03.246

Authors: Angeles Alvarez Secord, Michael McCollum, Brittany A. Davidson, Gloria Broadwater, Robert Squatrito, Laura J. Havrilesky, Anne C. Gabel, Mark D. Starr, J. Chris Brady, Andrew B. Nixon, Linda R. Duska

Institutions: Duke University, Duke Cancer Institute, Virginia Oncology Associates, University of Virginia

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2934498937

FWCI: 3.187

Cites: 30

Cited by: 29

Related to: 10